Published Date: 26 Apr 2023
One million Americans currently have Parkinson's disease, and another 90,000 are diagnosed with it each year. It is currently the second most prevalent neurodegenerative disease in the country. And it's moving up to No. 1. However, few people are familiar with Parkinson's.
Read Full News1.
Predicting adult mortality from oral cancer using a machine learning approach.
2.
Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer
3.
Liver cancer cells under pressure: Compression can spark invasion, drug resistance and altered gene activity
4.
Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival
5.
In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.
1.
Decoding the Failures in Acute Myeloid Leukemia Treatment: Mechanisms, Pathways, & Survival Outcomes
2.
Amivantamab Plus Chemotherapy Outperforms Standard Care in Post-Osimertinib NSCLC
3.
Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More
4.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
5.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
2.
Navigating the Complexities of Ph Negative ALL - Part VI
3.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
4.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation